Milestone Pharmaceuticals is trading at $0.75, up 6.73% in after-hours trading, with the catalyst unconfirmed. - No verified company-specific announcement dated October 22 explains the rise. - Its latest listed release, dated October 19, announced clinical data presentations at upcoming cardiology conferences, including one scheduled for October 22; that timing alone does not confirm a catalyst. - Broader markets were mixed to lower while Milestone Pharmaceuticals rose, leaving the supplied market context inconclusive.